Results 161 to 170 of about 23,180 (193)

Less Is More? Two Cases of Cryptococcosis Treated Using Single-dose Liposomal Amphotericin B as Part of Induction Therapy in Solid Organ Transplant Recipients. [PDF]

Transplant Direct
Lo CKL, Rampersad C, Barr J, Husain S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Liposomal amphotericin B, AmBisome

Journal of Infection, 1994
The unilamellar liposomal formulation of amphotericin B, AmBisome, is composed of hydrogenated soy phosphatidylcholine, distearoyl phosphatidylglycerol and cholesterol. Early studies of its efficacy in an open design showed that remissions could be induced in candidosis and aspergillosis and that doses of up to 5 mg/kg could be used.
openaire   +2 more sources

Amphotericin B/amphotericin B liposomal

Reactions Weekly, 2023
openaire   +2 more sources

Amphotericin-B-liposomal

Reactions Weekly, 2023
  +5 more sources

Amphotericin-B/amphotericin-B-liposomal

Reactions Weekly, 2020
openaire   +1 more source

Amphotericin-b/amphotericin-b-liposomal/posaconazole

Reactions Weekly, 2023
openaire   +1 more source

Amphotericin-B/amphotericin-B liposomal

Reactions Weekly, 2016
openaire   +2 more sources

Amphotericin B/amphotericin B liposomal

Reactions Weekly, 2004
openaire   +1 more source